文献速递先天性心脏病外科

聚四氟乙烯带瓣管道的中期结局

Midterm Outcomes for Polytetrafluoroethylene Valved Conduits.
PubMed 文献 · Ann Thorac Surg · 2021-10-27

该回顾性研究纳入2014年1月至2020年6月期间72例使用膨体聚四氟乙烯(ePTFE)带瓣管道行右心室流出道重建的患者,中位随访33个月。无早期死亡,2例晚期死亡(2.78%);5例出现管道功能障碍,无需再次干预或管道置换;法洛四联症修复术后右心室舒张末期容积指数显著下降(171 mL/m2 vs 130 mL/m2;P < .001)。作者认为该手工缝制ePTFE带瓣管道中期血流动力学结局可接受,需长期随访研究证实。

要点

  • 72例ePTFE带瓣管道右心室流出道重建患者中位随访33个月,无早期死亡,晚期死亡2例(2.78%)。
  • ePTFE瓣峰值流速2.38 m/s(95% CI,2.11-2.63 m/s),肺动脉瓣反流无或微量27例(38.5%)、轻度42例(60.0%)、中度1例(1.4%)。
  • 5例发生管道功能障碍(4例中度狭窄、1例中度反流),无需再次干预或管道置换。

核心结论

  • 该手工缝制ePTFE带瓣管道在中位随访33个月期间血流动力学结局可接受,需长期随访研究证实。

研究设计与样本

  • 回顾性研究,纳入2014年1月至2020年6月期间72例使用ePTFE带瓣管道行右心室流出道重建的患者。

主要发现

  • 患者中位年龄69个月(四分位距,28-127个月),中位随访33个月(四分位距,9-51个月)。
  • 无早期死亡,发生2例晚期死亡(2.78%)。
  • 管道中位尺寸18 mm(四分位距,18-20 mm),z评分+1.3(四分位距,+0.6至+2)。
  • ePTFE瓣峰值流速2.38 m/s(95% CI,2.11-2.63 m/s)。
  • 肺动脉瓣反流无或微量27例(38.5%)、轻度42例(60.0%)、中度1例(1.4%);管道功能障碍5例,其中中度管道狭窄4例、中度反流1例。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。
  • 作者指出需长期随访研究证实这些发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Various conduits for right ventricular outflow tract reconstruction have been reported, but most of them are not available in China. The study investigators developed a simple handsewn valved conduit using expanded polytetrafluoroethylene (ePTFE). This study evaluated the midterm outcomes for this conduit. METHODS: This retrospective study included a total of 72 patients who underwent right ventricular outflow tract reconstruction with ePTFE valved conduits between January 2014 and June 2020. During follow-up, echocardiograms were performed for all patients, and magnetic resonance imaging was performed for patients with repaired tetralogy of Fallot. RESULTS: Patients had a median age of 69 months (interquartile range, 28-127 months) and a median follow-up period of 33 months (interquartile range, 9-51 months). There was no early death, but 2 late deaths (2.78%) occurred. The median conduit size was 18 mm (interquartile range, 18-20 mm) and the z score was +1.3 (interquartile range, +0.6-+2). Peak velocity across the ePTFE valve was 2.38 m/s (95% CI, 2.11-2.63 m/s). Pulmonary valve regurgitation was none or trivial in 27 (38.5%) patients, mild in 42 (60.0%) patients, and moderate in 1 (1.4%) patient. Conduit dysfunction occurred in 5 patients: 4 had moderate conduit stenosis, and 1 had moderate regurgitation. The right ventricular end-diastolic volume index in repaired tetralogy of Fallot was significantly decreased after surgery (171 mL/m2 vs 130 mL/m2; P < .001). No reintervention or conduit replacement was needed. CONCLUSIONS: This handsewn ePTFE valved conduit was associated with appreciable hemodynamic outcomes during the midterm follow-up period. Long-term follow-up studies are needed to corroborate these findings.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Shi Q, Shan Y, Chen G, et al. Midterm Outcomes for Polytetrafluoroethylene Valved Conduits. Ann Thorac Surg. 2021. PMID: 34717907. doi:10.1016/j.athoracsur.2021.09.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。